Inhalant Addiction Treatment in Chattanooga

Inhalant addiction is one of the most underreported and misunderstood substance use disorders — and one of the most dangerous. The products involved are legal, inexpensive, and found in nearly every home: aerosol sprays, cleaning fluids, markers, glue, gasoline, and pressurized gases. Because they are so ordinary, the seriousness of inhalant dependency is frequently minimized. That minimization costs lives.

At Tovli Recovery, located at 6918 Shallowford Road in Chattanooga, Tennessee, we treat inhalant addiction with the same clinical seriousness as any other substance use disorder. Our outpatient programs — Partial Hospitalization, Intensive Outpatient, and Standard Outpatient — provide structured, evidence-based care in a compassionate environment designed to support genuine, lasting recovery for individuals and families in Hamilton County and across East Tennessee.

If inhalant use is affecting your life or the life of someone you care about, this page will give you a clear picture of what treatment involves, what to expect from recovery, and how to take the first step today.

Concerned About Inhalant Use? We Can Help.

Reach out confidentially to our Chattanooga admissions team. Most major insurance accepted. | (423) 455-9483

Inhalant addiction — also called Inhalant Use Disorder — is the compulsive, repeated misuse of chemical vapors to produce a psychoactive effect. The substances involved are not manufactured as drugs. They are industrial solvents, household aerosols, and common consumer products repurposed for intoxication. This is precisely what makes inhalant addiction so difficult to detect and so dangerous: the substances are everywhere, they are cheap, and the social stigma around taking them seriously often delays treatment.

When inhaled, volatile chemicals enter the bloodstream almost instantly through the lungs, reaching the brain within seconds. The result is a brief, intense high — typically lasting between five and thirty minutes — that mimics alcohol intoxication. Because the effect fades so quickly, users often inhale repeatedly in a single session, dramatically increasing exposure to toxic compounds with every cycle.

Inhalant addiction can develop in a matter of weeks. The brain begins to associate the chemical high with relief, escape, or excitement, establishing a compulsive use pattern that becomes increasingly difficult to interrupt without structured professional support.

Who Is at Risk for Inhalant Addiction?

Inhalant use cuts across demographics, but certain groups carry elevated risk. Adolescents and young adults represent the most commonly affected population — the accessibility and low cost of inhalants make them an early entry point for substance use among young people in Chattanooga and across Tennessee. However, adults with chronic inhalant use histories, individuals in environments with limited access to other substances, and those using inhalants to self-medicate stress or trauma are also well represented in treatment settings.

Research from SAMHSA and NIDA consistently identifies inhalants as among the substances most likely to cause irreversible organ and neurological damage — even after limited use. Early treatment is not just beneficial; it is urgent.

Types of Inhalants Commonly Misused

Inhalants span a wide range of household and industrial products, organized into four main categories:

• Volatile Solvents:  Paint thinner, gasoline, lighter fluid, correction fluid, felt-tip marker fluid, glue, and cleaning fluids.
• Aerosols:  Spray paint, hair spray, deodorant sprays, vegetable oil sprays, and aerosol computer cleaning products.
• Gases:  Butane lighters, propane tanks, whipping cream aerosols (nitrous oxide), and refrigerants.
• Nitrites:  Often sold as room deodorizers or leather cleaners, nitrites are a distinct subcategory used primarily for their vasodilating effects.

Because inhalant use involves everyday products and leaves few obvious traces, it is often hidden in plain sight. Knowing the warning signs — behavioral, physical, and environmental — is critical for early identification and intervention.

Behavioral Warning Signs

• Unexplained periods of confusion, disorientation, or apparent intoxication with no alcohol or drug smell
• Withdrawal from family, friends, and previously valued activities
• Declining performance at school, work, or in daily responsibilities
• Increased secrecy around personal spaces, bags, or belongings
• Disappearance of household chemical products or frequent unexplained purchases
• Loss of interest in hobbies, goals, or relationships that previously mattered

Physical Warning Signs

• Chemical odors on breath, clothing, or hair that cannot be explained
• Paint, solvent, or marker stains around the mouth, nose, or fingers
• Red or irritated skin around the nose and mouth from repeated exposure
• Frequent nosebleeds, persistent headaches, or unexplained nausea
• Tremors, impaired coordination, or slurred speech
• Watery or bloodshot eyes
• Unexplained fatigue or profound drowsiness

Psychological and Cognitive Warning Signs

• Significant mood swings, irritability, or emotional unpredictability
• Memory lapses, difficulty concentrating, or confusion about recent events
• Apathy, flattened affect, or diminished emotional engagement
• Anxiety or agitation when access to inhalants is restricted
• Depression that worsens over time despite no clear life circumstances causing it

If you recognize multiple signs in yourself or someone you care about, professional evaluation is the appropriate next step. Inhalant addiction does not resolve on its own, and the neurological and organ damage it causes accumulates with every episode of use. Early intervention at Tovli Recovery in Chattanooga can interrupt this trajectory before damage becomes permanent.

Inhalant misuse is underreported at both local and national levels, largely because the substances involved are not tracked through the same channels as illicit drugs. However, treatment providers across Tennessee — including Chattanooga and Hamilton County — encounter inhalant use disorder regularly, particularly among adolescents, young adults, and individuals with long histories of polysubstance use.

The Tennessee Department of Mental Health and Substance Abuse Services has identified inhalant use as a concern within youth substance use prevention programs statewide, and national SAMHSA data consistently places inhalants among the most commonly tried substances among young people aged 12 to 17 — often preceding other substance use.

Despite this, specialized outpatient inhalant addiction treatment in the Chattanooga area remains limited. Tovli Recovery fills this gap — offering structured, evidence-based outpatient care at 6918 Shallowford Road for individuals and families who need professional treatment close to home, without residential placement.

Tovli Recovery | 6918 Shallowford Road, Chattanooga, TN 37421 | (423) 455-9483 | Serving Chattanooga, Hamilton County, East Ridge, Red Bank, Hixson, and surrounding East Tennessee communities.

Inhalants are among the most neurotoxic substances a person can be exposed to — and unlike most other drugs, their damage can begin with the very first use. The chemical compounds in inhalants are lipid-soluble, meaning they dissolve readily in fat-rich tissue. The brain, which is composed largely of fatty tissue, absorbs these chemicals rapidly and sustains damage at every level of exposure.

Immediate and Short-Term Health Risks

• Sudden Sniffing Death Syndrome: Cardiac arrhythmia triggered by inhalant exposure can cause fatal heart failure within minutes — even in first-time users and individuals with no prior cardiac history. This is the most acute risk of inhalant use and can occur without warning.
• Oxygen deprivation and asphyxiation: Displacing oxygen in the lungs during use can cause unconsciousness or death, particularly when inhalants are used with bags over the head or in enclosed spaces.
• Loss of consciousness and traumatic injury: Sudden disorientation and incapacitation during use creates significant risk of falls, accidents, and physical trauma.
• Seizures: Chemical exposure can trigger seizure activity, particularly in individuals with underlying neurological vulnerabilities.
• Severe nausea and vomiting with aspiration risk: Aspiration of vomit during an episode of reduced consciousness is a documented cause of inhalant-related death.

Long-Term Health Consequences

• Permanent brain damage: Chronic inhalant exposure destroys myelin — the protective sheath surrounding nerve fibers — causing irreversible cognitive impairment, memory loss, and difficulties with attention, reasoning, and motor coordination.
• Hearing and vision loss: Certain solvents cause permanent damage to the auditory and optic nerves with prolonged exposure.
• Liver and kidney damage: The liver and kidneys, responsible for filtering chemical toxins, sustain significant damage with repeated inhalant use, potentially progressing to organ failure.
• Peripheral neuropathy: Nerve damage in the hands, feet, and limbs results in numbness, tingling, weakness, and loss of fine motor control.
  Chronic respiratory damage: Repeated chemical exposure irritates and damages lung tissue, reducing respiratory capacity over time.
• Bone marrow toxicity: Certain inhalants (particularly benzene-containing solvents) suppress bone marrow function, reducing blood cell production and immune capacity.

For individuals who are medically stable and do not require acute medical detoxification, outpatient addiction treatment is an appropriate and effective level of care for inhalant use disorder. Outpatient programs allow individuals to receive structured, intensive clinical treatment during the day or evening while continuing to live at home — maintaining employment, family roles, and connection to their support networks.

The behavioral and psychological dimensions of inhalant addiction — compulsive use patterns, emotional dysregulation, trauma histories, cognitive impacts — are all addressed within Tovli Recovery’s evidence-based outpatient programming. Critically, outpatient care also allows therapy work to be applied in real-life settings immediately, which is especially important for inhalant addiction given that the triggering substances exist within ordinary daily environments.

Outpatient treatment at Tovli Recovery is well suited for individuals who:

• Are medically stable following inhalant use and do not require acute medical monitoring
• Have a safe and supportive home environment free from active inhalant use
• Are motivated to engage in structured treatment and recovery work
• Need to maintain employment, education, or caregiving responsibilities during treatment
• Are stepping down from a higher level of care and need continued clinical structure

Tovli Recovery offers three structured outpatient levels of care, each calibrated to deliver the right intensity of treatment based on your clinical needs, life circumstances, and recovery stage. Our admissions team will work with you during a confidential assessment to identify your optimal starting point and support smooth transitions between levels as your recovery progresses.

Partial Hospitalization Program (PHP)

PHP is the most intensive level of outpatient care at Tovli Recovery, providing full-day structured programming — typically five days per week — without requiring an overnight stay. It delivers the clinical depth of residential care while allowing individuals to return to a stable home environment each evening. For inhalant addiction, Partial hospitalization program is particularly well suited to individuals in early recovery who need a high level of daily structure, accountability, and clinical monitoring to establish and reinforce sobriety.

What PHP includes for inhalant addiction treatment:

• Daily individual therapy with a licensed addiction counselor to address inhalant-specific use patterns and underlying drivers of use
• Morning and afternoon group therapy sessions focused on recovery skills, peer accountability, and emotional processing
• Comprehensive psychoeducation on inhalant toxicity, brain health, and the physical recovery process
• Cognitive rehabilitation support for individuals experiencing cognitive effects from inhalant exposure
• Structured daily schedule to rebuild routine, purpose, and stability in early recovery
• Regular clinical team reviews with plan adjustments based on progress
• Coordinated step-down planning when transition to IOP is clinically appropriate

PHP is often the right entry point for individuals with moderate-to-severe inhalant use histories, those who have attempted to stop on their own without success, or anyone whose home environment carries meaningful risk during early recovery.

Intensive Outpatient Program (IOP)

Intensive outpatient program provides consistent, meaningful clinical engagement — typically three hours per day, three to five days per week — with scheduling flexibility that accommodates employment, education, and family responsibilities. It is Tovli Recovery’s most utilized level of care and is designed for individuals who are motivated for recovery, have adequate home support, and benefit from regular therapeutic structure without full-day programming requirements.

What IOP includes for inhalant addiction treatment:

• Individual and group counseling grounded in CBT, Motivational Interviewing, and evidence-based relapse prevention approaches
• Identification and coping skill development for inhalant-specific triggers — including environmental and emotional cues tied to everyday product exposure
• Peer support group engagement within a structured, professionally facilitated setting
• Family involvement opportunities to rebuild trust and strengthen home-based recovery support
• Morning and evening schedule options to accommodate work or caregiving commitments
• Regular progress reviews and transition planning between levels of care

IOP is appropriate as a primary entry level for individuals with moderate inhalant use histories and stable circumstances, and as a step-down from PHP as early recovery consolidates.

Standard Outpatient Program (OP)

Standard Outpatient Program is the final structured level of care before transitioning to community-based recovery support. Sessions are less frequent — typically one to two days per week — and serve individuals who have built genuine recovery stability and are ready to integrate that stability into fully independent daily life while maintaining clinical touchpoints.

What Standard OP includes for inhalant addiction treatment:

• Ongoing individual counseling to reinforce recovery skills and address emerging life challenges
• Continued group therapy and peer accountability
• Long-term relapse prevention planning — including strategies specific to inhalant triggers in everyday environments
• Life skills development, vocational support, and relationship rebuilding
• Aftercare coordination and alumni transition support

Standard OP ensures that the clinical gains built during PHP or IOP are not lost in the transition to independence. It is a bridge — not an ending — and an important safeguard during the vulnerable later stages of early recovery.

Not Sure Which Level of Care Is Right?

Our admissions team will guide you to the right starting point — confidentially, without pressure. | (423) 455-9483

There are currently no FDA-approved medications specifically indicated for inhalant use disorder. As with cannabis addiction, behavioral therapy is the clinical backbone of effective inhalant addiction treatment — and its effectiveness is well established when delivered consistently and tailored to the individual. At Tovli Recovery, our therapists draw from a range of evidence-based approaches proven to reduce substance use, address underlying vulnerabilities, and build durable recovery skills.

Cognitive Behavioral Therapy (CBT)

CBT is the most researched and widely recommended therapy for substance use disorders, including inhalant addiction. For inhalant use specifically, CBT helps individuals identify the thought patterns, emotional states, and situational triggers that precipitate use — and develop concrete, practiced alternatives. Because inhalant triggers often include ordinary environments and commonplace products, building specific cognitive and behavioral responses to these cues is a central focus of CBT work at Tovli Recovery.

Motivational Interviewing (MI)

Many individuals entering treatment for inhalant addiction carry significant ambivalence — they recognize the harm but feel uncertain about a life without the relief or escape inhalants have provided. Motivational Interviewing is a collaborative, empathic counseling approach that meets clients where they are, explores the tension between current behavior and personal values, and strengthens intrinsic motivation for change without confrontation or pressure. It is particularly effective in early treatment stages.

Trauma-Informed Care

Trauma and adverse childhood experiences are significantly overrepresented in inhalant addiction histories. Many individuals who develop inhalant dependency began use during adolescence as a way of coping with emotional pain, instability, or trauma. Tovli Recovery’s clinical approach is trauma-informed at every level — meaning therapists are trained to recognize how trauma shapes addiction patterns, and treatment is delivered in ways that avoid retraumatization while supporting genuine healing.

Relapse Prevention Therapy

Inhalant relapse prevention requires attention to a unique challenge: the triggering substances are present in daily life in a way that illicit drugs are not. Treatment at Tovli Recovery includes the development of detailed, personalized relapse prevention plans that account for inhalant-specific exposure risks — at home, in retail environments, and at work. You will learn to recognize early warning signs, manage cravings, and implement structured responses before a full relapse occurs.

Family Counseling and Support

Inhalant addiction affects the entire family system — often dramatically, given the visible nature of its physical effects and the shock many families experience upon discovering the extent of use. Tovli Recovery incorporates family counseling as a component of treatment when appropriate, helping rebuild communication, trust, and realistic expectations for the recovery process. Families are educated about inhalant addiction as a medical condition and given tools to provide support without enabling continued use.

Group Therapy and Peer Recovery Support

Group therapy provides the peer accountability, shared experience, and community connection that are central to sustainable recovery from any substance use disorder. Within a facilitated group environment at Tovli Recovery, individuals in treatment for inhalant addiction build relationships with peers who understand the complexity and shame that often surrounds this specific form of substance use — and experience the normalizing, motivating power of a shared recovery community.

Getting started with treatment can feel like an enormous step. Here is a transparent, step-by-step picture of what the process looks like at Tovli Recovery from first contact through ongoing recovery:

1. Confidential Pre-Assessment: You contact our admissions team through our secure contact form or by phone. An admissions specialist speaks with you privately — no judgment, no pressure — about your inhalant use history, current situation, and what you want from treatment.
2. Insurance Verification: Our team verifies your insurance benefits at no cost and explains exactly what your plan covers for outpatient inhalant addiction treatment before any decisions are made. We accept Blue Cross Blue Shield, Aetna, Cigna, United Healthcare, Humana, and most major carriers.
3. Clinical Assessment and Treatment Planning: A clinical assessment identifies the appropriate level of care, relevant trauma history, cognitive impacts of inhalant use, and treatment goals. Your personalized plan is built before your first day of programming.
4. Program Entry: You begin your chosen level of care — PHP, IOP, or Standard OP — with a clear schedule, a dedicated counselor, and a full clinical team supporting your progress from day one.
5. Ongoing Progress Reviews: Your treatment plan is reviewed regularly. Transitions between levels of care are guided by genuine clinical progress — you step down when you are ready, not on an arbitrary calendar.
6. Aftercare and Continuing Care Planning: Before completing your program, you and your clinical team build a comprehensive continuing care plan — covering peer support connections, community resources, alumni engagement, and any ongoing counseling needs.

Inhalant withdrawal differs from opioid or alcohol withdrawal in important ways. Unlike those substances, inhalant dependence does not typically produce the severe physiological withdrawal syndromes that require acute medical detoxification. However, the psychological withdrawal from inhalant addiction is real, uncomfortable, and a significant driver of relapse in the days and weeks following cessation.

Common Inhalant Withdrawal Experiences

• Intense cravings, often tied to specific environments, emotional states, or sensory cues
• Irritability, agitation, and emotional volatility
• Persistent headaches and generalized physical discomfort
• Sleep disturbances — including difficulty falling asleep and abnormal dream patterns
• Anxiety, restlessness, and an inability to experience calm without the substance
• Low mood, apathy, and a temporary inability to feel pleasure — a consequence of inhalant-induced dopamine system disruption
• Cognitive fog, difficulty concentrating, and short-term memory difficulties

The intensity and duration of withdrawal symptoms varies based on the length and severity of inhalant use, the specific substances involved, and individual neurological factors. For individuals with long-term, heavy use histories, some cognitive and mood-related symptoms may persist for weeks to months as the brain slowly heals.

Having structured outpatient support in place during this period — through PHP or IOP at Tovli Recovery — provides the daily accountability, therapeutic tools, and clinical monitoring that make this window navigable. It is precisely when withdrawal symptoms are most intense that having a clinical team and a peer community available makes the greatest difference in whether someone stays on the recovery path or returns to use.

Completing a structured treatment program is a landmark achievement — and the foundation for what comes next. At Tovli Recovery, recovery support does not end at program discharge. Lasting recovery from inhalant addiction requires ongoing connection, continued skill application, and a community that understands the journey.

Continuing care and recovery support for inhalant addiction may include:

• Ongoing individual counseling on a reduced schedule to maintain progress and address post-treatment challenges
• Participation in SMART Recovery, Narcotics Anonymous, or other community-based peer support programs available in the Chattanooga area
• Sober living referrals for individuals who need a structured, substance-free environment during extended early recovery
• Home-based outpatient aftercare support through Tovli Recovery’s continuing care services
• Alumni community connection and events through Tovli Recovery’s ongoing alumni programming
• Vocational and educational support to rebuild momentum in areas disrupted by inhalant addiction
• Environmental planning support — practical strategies for managing inhalant triggers in home, work, and retail environments on a daily basis

One of the unique challenges of long-term inhalant addiction recovery is the ongoing presence of the triggering substances in ordinary life. Recovery support at Tovli Recovery includes specific, practical work on environmental management — building the habits, awareness, and responses that protect sobriety even when the substances themselves remain within arm’s reach.

Discovering that a family member is struggling with inhalant addiction is frequently a shock — in part because the substances involved are so ordinary and because the signs are easy to overlook or explain away until the pattern has become well established. Your concern is warranted, and acting on it promptly can make a genuine difference in outcomes.

Steps Family Members Can Take

• Educate yourself about Inhalant Use Disorder as a medical condition — this shifts the frame from moral judgment to practical support and makes it easier to have an honest conversation without triggering shame or defensiveness.
• Choose a calm, sober moment to express your concern clearly and without ultimatums. Focus on what you have observed, how it has affected the person you care about, and that you want to help them access professional support.
• Research treatment options in advance. Being able to say “I found a program at Tovli Recovery in Chattanooga — can we call them together today?” removes one of the barriers between intention and action.
• Contact our admissions team directly. We speak with family members confidentially, answer questions about what treatment involves, and help you understand how to support a loved one’s entry into care.
• Understand the difference between support and enabling. Supporting recovery means encouraging treatment-seeking and maintaining clear boundaries — not absorbing consequences or providing cover for continued use.
• Take care of your own wellbeing. Nar-Anon and Al-Anon offer peer support groups in Chattanooga and surrounding communities for families affected by a loved one’s addiction.

Family involvement, when welcomed by the person in treatment, is a meaningful predictor of recovery success. Tovli Recovery incorporates family engagement into our clinical programming and welcomes calls from family members who want to understand the process or explore how to help.

The cost of addiction treatment should never be the reason someone does not get help. At Tovli Recovery, we take a proactive, insurance-first approach to admissions — verifying your benefits before treatment begins and explaining your coverage clearly so you can make informed decisions without financial uncertainty.

Under the Affordable Care Act and the Mental Health Parity and Addiction Equity Act, most health insurance plans are required to cover substance use disorder treatment — including outpatient programs for inhalant addiction — at parity with other medical care. In many cases, PHP, IOP, and Standard Outpatient treatment at Tovli Recovery is meaningfully covered by your existing plan.

Insurance Plans Accepted at Tovli Recovery

• Blue Cross Blue Shield (BCBS) — including BlueCare Tennessee and BCBS Federal Employee Program
• Aetna
• Cigna
• United Healthcare
• Humana
• Most other major commercial insurance carriers

Our admissions team completes insurance verification at no charge, typically within the same day you reach out. We explain your benefits in plain language — what is covered, what your out-of-pocket responsibilities are, and how to maximize your plan for the level of care you need.

If you are uninsured or underinsured, please still reach out. We will explore every available pathway — payment plans, financial assistance, and other options — because access to quality addiction treatment should not depend on financial circumstances.

Verify Your Insurance — Free, Confidential, No Commitment

Know your coverage before your first appointment. Verify Insurance  |  (423) 455-9483

Specialized, accessible outpatient treatment for inhalant addiction in Chattanooga is limited. Tovli Recovery was established to close that gap — bringing evidence-based, clinically rigorous outpatient care to Hamilton County and East Tennessee without requiring residential placement or out-of-state travel.

• Local and accessible: Our Shallowford Road location puts professional inhalant addiction treatment within reach for Chattanooga residents, close to home, work, and family.
• All three outpatient levels under one clinical team: PHP, IOP, and Standard OP allow seamless, supported transitions as your recovery progresses — with the same team, the same therapeutic relationships, and the same clinical environment throughout.
• Therapy-first clinical model: With no medications approved specifically for inhalant use disorder, the quality of behavioral therapy defines treatment outcomes. Our clinicians are trained in CBT, Motivational Interviewing, trauma-informed care, and evidence-based relapse prevention.
• Inhalant-specific environmental recovery planning: We address the unique challenge of managing exposure to triggering substances that exist within ordinary daily life — building practical, personalized strategies that most generic programs overlook.
• Insurance-first admissions: We verify your benefits before treatment begins and ensure you have full financial clarity from day one.
• Trauma-informed across all programs: Recognizing that trauma frequently underlies inhalant addiction, our clinical approach is designed to support healing without retraumatization.
• Clinical leadership with depth: Tovli Recovery’s programs are shaped by Casey Bright, whose more than 20 years building CARF-accredited addiction treatment programs across multiple states defines the clinical standards our team delivers.

Inhalant addiction is serious. It moves fast, it causes real damage, and it does not resolve without professional support. But it is also treatable — and recovery is possible at every stage, for every person, regardless of how long use has continued or how severe it has become.

At Tovli Recovery in Chattanooga, Tennessee, we offer structured, compassionate outpatient programs — PHP, IOP, and Standard Outpatient care — at 6918 Shallowford Road, close to where you live and work in Hamilton County. Our clinical team is experienced, our admissions process is transparent, and our programs are built around your specific history, goals, and circumstances.

You do not need to have everything figured out to reach out. You just need to be willing to take one step. We will help with everything that follows.